Literature DB >> 22851488

Vasomotor symptoms and insulin resistance in the study of women's health across the nation.

Rebecca C Thurston1, Samar R El Khoudary, Kim Sutton-Tyrrell, Carolyn J Crandall, Barbara Sternfeld, Hadine Joffe, Ellen B Gold, Faith Selzer, Karen A Matthews.   

Abstract

CONTEXT: Emerging research suggests links between menopausal hot flashes and cardiovascular disease risk. The mechanisms underlying these associations are unclear, due to the incomplete understanding of the physiology of hot flashes. OBJECTIVE AND MAIN OUTCOME MEASURES: We examined the associations between hot flashes/night sweats and glucose and insulin resistance over 8 yr, controlling for cardiovascular risk factors and reproductive hormones. DESIGN, SETTING, AND PARTICIPANTS: Participants in the Study of Women's Health Across the Nation (SWAN) (n=3075), a longitudinal cohort study, were ages 42-52 yr at entry. Women completed questionnaires (hot flashes, night sweats: none, 1-5 d, ≥6 d, past 2 wk), physical measures (blood pressure, height, weight), and a fasting blood draw [serum glucose, insulin, estradiol (E2), FSH] annually for 8 yr. Hot flashes/night sweats were examined in relation to glucose and the homeostasis model assessment (HOMA) in mixed models, adjusting for demographics, cardiovascular risk factors, medications, and E2/FSH.
RESULTS: Compared to no flashes, hot flashes were associated with a higher HOMAlog index [vs. none; hot flashes, 1-5 d: % difference (95% confidence interval), 2.37 (0.36-4.43), P=0.02; and ≥6 d: 5.91 (3.17-8.72), P<0.0001] in multivariable models that included body mass index. Findings persisted adjusting for E2 or FSH, and were similar for night sweats. Findings were statistically significant, yet modest in magnitude, for the outcome glucose.
CONCLUSIONS: Hot flashes were associated with a higher HOMA index, an estimate of insulin resistance, and to a lesser extent higher glucose. Metabolic factors may be relevant to understanding the link between hot flashes and cardiovascular disease risk.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22851488      PMCID: PMC3462945          DOI: 10.1210/jc.2012-1410

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Authors:  Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

2.  Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women.

Authors:  Gerrie-Cor M Gast; Göran N Samsioe; Diederick E Grobbee; Peter M Nilsson; Yvonne T van der Schouw
Journal:  Maturitas       Date:  2010-04-18       Impact factor: 4.342

3.  Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN).

Authors:  Rachel P Wildman; Alicia B Colvin; Lynda H Powell; Karen A Matthews; Susan A Everson-Rose; Steven Hollenberg; Janet M Johnston; Kim Sutton-Tyrrell
Journal:  Menopause       Date:  2008 May-Jun       Impact factor: 2.953

4.  Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study.

Authors:  Rebecca C Thurston; Kim Sutton-Tyrrell; Susan A Everson-Rose; Rachel Hess; Karen A Matthews
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

5.  Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women's Health Across the Nation.

Authors:  Nancy E Avis; Alicia Colvin; Joyce T Bromberger; Rachel Hess; Karen A Matthews; Marcia Ory; Miriam Schocken
Journal:  Menopause       Date:  2009 Sep-Oct       Impact factor: 2.953

6.  Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women's health across the nation.

Authors:  Rebecca C Thurston; MaryFran R Sowers; Barbara Sternfeld; Ellen B Gold; Joyce Bromberger; Yuefang Chang; Hadine Joffe; Carolyn J Crandall; L Elaine Waetjen; Karen A Matthews
Journal:  Am J Epidemiol       Date:  2009-08-12       Impact factor: 4.897

7.  Hot flashes and cardiac vagal control: a link to cardiovascular risk?

Authors:  Rebecca C Thurston; Israel C Christie; Karen A Matthews
Journal:  Menopause       Date:  2010 May-Jun       Impact factor: 2.953

8.  Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women.

Authors:  Howard M Kravitz; Xinhua Zhao; Joyce T Bromberger; Ellen B Gold; Martica H Hall; Karen A Matthews; MaryFran R Sowers
Journal:  Sleep       Date:  2008-07       Impact factor: 5.849

9.  Evidence for a role of hot flushes in vascular function in recently postmenopausal women.

Authors:  Pauliina Tuomikoski; Pia Ebert; Per-Henrik Groop; Petri Haapalahti; Hanna Hautamäki; Mats Rönnback; Olavi Ylikorkala; Tomi S Mikkola
Journal:  Obstet Gynecol       Date:  2009-04       Impact factor: 7.661

10.  Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women.

Authors:  Alison J Huang; George F Sawaya; Eric Vittinghoff; Feng Lin; Deborah Grady
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 3.310

View more
  32 in total

1.  Postmenopausal Symptoms in Female Veterans with Type 2 Diabetes: Glucose Control and Symptom Severity.

Authors:  Patricia A Rouen; Sarah L Krein; Nancy E Reame
Journal:  J Womens Health (Larchmt)       Date:  2015-05-04       Impact factor: 2.681

Review 2.  Perimenopause as a neurological transition state.

Authors:  Roberta D Brinton; Jia Yao; Fei Yin; Wendy J Mack; Enrique Cadenas
Journal:  Nat Rev Endocrinol       Date:  2015-05-26       Impact factor: 43.330

3.  Association between gaseous air pollutants and inflammatory, hemostatic and lipid markers in a cohort of midlife women.

Authors:  Xiangmei May Wu; Rupa Basu; Brian Malig; Rachel Broadwin; Keita Ebisu; Ellen B Gold; Lihong Qi; Carol Derby; Rochelle S Green
Journal:  Environ Int       Date:  2017-07-26       Impact factor: 9.621

4.  Reproductive endocrinology: menopausal vasomotor symptoms and insulin resistance.

Authors:  Emily D Szmuilowicz
Journal:  Nat Rev Endocrinol       Date:  2012-10-02       Impact factor: 43.330

5.  Changes in heart rate variability during vasomotor symptoms among midlife women.

Authors:  Rebecca C Thurston; Karen A Matthews; Yuefang Chang; Nanette Santoro; Emma Barinas-Mitchell; Roland von Känel; Doug P Landsittel; J Richard Jennings
Journal:  Menopause       Date:  2016-05       Impact factor: 2.953

6.  Predictors of vasomotor symptoms among breast cancer survivors.

Authors:  Katherine W Reeves; Michael Pennell; Randi E Foraker; Carolyn J Crandall; Marcia Stefanick; Electra D Paskett
Journal:  J Cancer Surviv       Date:  2018-02-09       Impact factor: 4.442

7.  Measuring hot flash phenomenonology using ambulatory prospective digital diaries.

Authors:  William I Fisher; Rebecca C Thurston
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

Review 8.  Vasomotor symptoms: natural history, physiology, and links with cardiovascular health.

Authors:  R C Thurston
Journal:  Climacteric       Date:  2018-02-02       Impact factor: 3.005

9.  Trajectories of Vasomotor Symptoms and Carotid Intima Media Thickness in the Study of Women's Health Across the Nation.

Authors:  Rebecca C Thurston; Samar R El Khoudary; Ping Guo Tepper; Elizabeth A Jackson; Hadine Joffe; Hsiang-Yu Chen; Karen A Matthews
Journal:  Stroke       Date:  2015-11-17       Impact factor: 7.914

10.  Cardiovascular, hemodynamic, neuroendocrine, and inflammatory markers in women with and without vasomotor symptoms.

Authors:  Jennifer L Gordon; David R Rubinow; Rebecca C Thurston; Julia Paulson; Peter J Schmidt; Susan S Girdler
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.